Harvard Pilgrim Health Care Home
  Learn more.
  Sign up for HPHConnect.
Medical Management
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Office Support
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

February 2018

PCP Cardiac Medication Adherence Report

Are you familiar with Harvard Pilgrim’s Cardiac Medication Adherence report? On a semi-annual basis, Harvard Pilgrim sends a Cardiac Medication Adherence Report to PCPs for each patient discharged with an acute myocardial infarction (AMI), or heart attack, in the past two years. The report identifies patients who may require follow-up due to gaps in their adherence to beta blocker therapy and other cardiac medications.

The importance of beta blocker therapy after an AMI is widely recognized. According to the results of large-scale clinical trials, beta blockers consistently reduce subsequent coronary events, cardiovascular mortality, and all-cause mortality by 20 to 30 percent after an AMI when taken indefinitely. Today, according to published research, more than 90 percent of patients discharged from the hospital after having a heart attack receive beta blockers. Despite the proven long-term benefits of beta blockers, many patients don’t take the medication as prescribed after discharge.

In the Cardiac Medication Adherence Report, Harvard Pilgrim calculates beta blocker Proportion of Days Covered (PDC) — the sum of days' supply for all beta blocker pharmacy claims divided by the number of days elapsed for that time period — for each patient discharged after having a heart attack. Our analysis revealed that from January to June 2016 only 60 percent of Harvard Pilgrim members achieved a PDC rate of 80% or higher to beta blocker therapy 6 months post AMI and for January to June 2017 that number was 70%.

The Cardiac Medication Adherence Report can help PCPs identify such gaps in care. It displays each patient’s: name and date of birth; AMI discharge date; most recent six-month refill history of cardiac medications; the prescribing physician’s name and phone number, and the patient’s beta blocker PDC rate. This report can help PCPs:

  • identify patients discharged with a diagnosis of an AMI,
  • identify specialist(s) caring for their patient,
  • review cardiac medication fill history,
  • identify non-adherence or discrepancies with a patient’s cardiac medications including beta blockers,
  • coordinate care with a specialist.

For more information about this report, please contact our Clinical Programs Department at 800-287-9793.

Email this article to a colleague   

Network Matters Archives

Download printer-friendly version


Changes to Negative Balance and Refund Processes

Maximum Dosages for Medical Drugs

Reminder: Prior Authorization for Genetic Testing

Saheli Boston Can Help Meet the Needs of South Asian Patients


Prior Authorization for Diabetes Management Devices

Coverage of Exondys 51 with Prior Authorization

PCP Cardiac Medication Adherence Report

Member Blood Pressure Quiz

Endoscopic Sinus Surgeries Medical Review Criteria Updates

Lyme/Tick-Borne Diseases: Use of Parenteral Antibiotics Criteria

P&T Committee Meeting Update

Specialty Pharmacy Update

Members’ Rights and Responsibilities

HEDIS Spotlight: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET)


Reminder: Use the Correct Form for Provider Changes for Quicker Service


Eric H. Schultz,
President and Chief Executive Officer

Robert Farias,
Senior Vice President, Network Strategy

Annmarie Dadoly,

Joseph O'Riordan,

Kristin Edmonston,
Production Coordinator